Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00142389Phase 2Completed
A Phase 2 trial of 23-valent pneumococcal polysaccharide vaccine, pneumococcal 7-valent conjugate vaccine in pneumococcal infection, sponsored by Johns Hopkins Bloomberg School of Public Health. Started Aug 2004; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00142389.